Udemy Inc (UDMY – Research Report) received a Hold rating and price target from William Blair analyst Stephen Sheldon yesterday. The ...

Fintel reports that on March 12, 2025, William Blair downgraded their outlook for Udemy (NasdaqGS:UDMY) from Outperform to ...

William Blair downgraded shares of Udemy (NASDAQ:UDMY – Free Report) from an outperform rating to a market perform rating in ...

Udemy Inc (UDMY – Research Report) received a Hold rating and price target from William Blair analyst Stephen Sheldon today. The company’s ...

(Bloomberg) -- JPMorgan Chase & Co. has hired William Kallop from William Blair & Co. for its mergers and acquisitions group focused on private equity firms and sovereign wealth funds. Kallop is ...

Investing.com -- William Blair upgraded Palantir Technologies (NASDAQ:PLTR) to Market Perform following a 33% selloff from $125 to $84 over the past three weeks, despite concerns over its valuation.

Autism software provider CentralReach has been looking for a potential buyer, according to multiple sources with knowledge of ...

Investing.com -- William Blair upgraded Palantir Technologies (NASDAQ:PLTR) to Market Perform following a 33% selloff from $125 to $84 over the past three weeks, despite concerns over its valuation.

William Blair currently has a “Neutral” rating and a $14.00 price target on the stock. The consensus estimate for Intellia Therapeutics’ current full-year earnings is ($5.07) per share. Get ...

Palantir (NASDAQ:PLTR) was upgraded to Market Perform from Underperform by William Blair, following the recent share price decline by the data analysis and artificial intelligence software firm.